GAPDHP38

Across TCGA pan-cancer cohorts, GAPDHP38 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated GAPDHP38 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher GAPDHP38 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP38 expression acts as an unfavorable survival marker, although some lineages such as COAD and SKCM show a favorable association.

MESO, LIHC, and BRCA are the cancer types where GAPDHP38 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Quartile	All	0.339	0.659	<.001	72	view →
LIHC	OS	Quartile	All	0.348	0.686	<.001	47	view →
BRCA	DFS	Quartile	All	0.861	0.936	.004	45	view →
CHOL	OS	Tertile	All	0.397	0.837	.006	27	view →
COAD	OS	Median	All	0.799	0.465	<.001	25	view →
LUAD	OS	Quartile	All	0.738	0.847	.010	17	view →
SKCM	OS	Quartile	III,IV	0.802	0.612	.007	16	view →
UCS	OS	Tertile	IV	0.756	0.253	.024	12	view →
SARC	DFS	Tertile	All	0.477	0.746	<.001	12	view →
READ	DFS	Tertile	IV	0.711	0.225	.027	10	view →
LUSC	OS	Quartile	All	0.873	0.747	.020	9	view →
KIRP	OS	Tertile	All	0.895	0.976	.009	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

GAPDHP38–MESO (OS)

Open the MESO breakdown →